OREGON PUBLIC EMPLOYEES RETIREMENT FUND - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 132 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
OREGON PUBLIC EMPLOYEES RETIREMENT FUND ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$133,044
-47.9%
6,217
-1.6%
0.00%
-33.3%
Q1 2023$255,459
-15.2%
6,317
-2.4%
0.00%
-25.0%
Q4 2022$301,077
-10.1%
6,472
+0.2%
0.00%
-20.0%
Q3 2022$335,000
+17.1%
6,458
+6.7%
0.01%
+25.0%
Q2 2022$286,000
-40.3%
6,051
-10.0%
0.00%
-20.0%
Q1 2022$479,000
-7.5%
6,727
-2.9%
0.01%
-16.7%
Q4 2021$518,000
+27.0%
6,927
-3.6%
0.01%
+20.0%
Q3 2021$408,000
+29.1%
7,1820.0%0.01%
+25.0%
Q2 2021$316,000
-10.7%
7,1820.0%0.00%0.0%
Q1 2021$354,000
+18.8%
7,182
+1.4%
0.00%0.0%
Q4 2020$298,000
+0.3%
7,082
+9.1%
0.00%0.0%
Q3 2020$297,000
-8.9%
6,4940.0%0.00%
-20.0%
Q2 2020$326,000
-2.4%
6,4940.0%0.01%
-16.7%
Q1 2020$334,000
-16.7%
6,4940.0%0.01%0.0%
Q4 2019$401,000
+2.8%
6,4940.0%0.01%
+20.0%
Q3 2019$390,000
-25.4%
6,494
+4.8%
0.01%
-28.6%
Q2 2019$523,000
-10.1%
6,194
+1.6%
0.01%
-12.5%
Q1 2019$582,000
+37.3%
6,094
+1.8%
0.01%
+14.3%
Q4 2018$424,0005,9840.01%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 476,042$45,472,00012.29%
Stonepine Capital Management, LLC 60,840$5,811,0003.34%
ACUTA CAPITAL PARTNERS, LLC 61,000$5,827,0002.77%
Virtus ETF Advisers LLC 10,634$1,016,0002.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 61,000$5,827,0002.15%
ARMISTICE CAPITAL, LLC 372,000$35,533,0001.94%
Matarin Capital Management, LLC 209,403$20,002,0001.46%
Monashee Investment Management LLC 50,000$4,776,0001.10%
Granahan Investment Management 151,322$14,454,0000.78%
ALGERT GLOBAL LLC 13,186$1,260,0000.72%
View complete list of ENANTA PHARMACEUTICALS INC shareholders